[New oral anticoagulants in patients with atrial fibrillation in a urban health center].
Centro de Salud Universitario La Paz, Unidad Docente de Medicina Familiar y Comunitaria, Badajoz, España.
Leoncio
L
Rodríguez Pérez
Centro de Salud Universitario La Paz, Unidad Docente de Medicina Familiar y Comunitaria, Badajoz, España.
Fabiola
F
Capilla Lozano
Centro de Salud Universitario La Paz, Unidad Docente de Medicina Familiar y Comunitaria, Badajoz, España.
Rogelio
R
Gallego Fuentes
Centro de Salud Universitario La Paz, Unidad Docente de Medicina Familiar y Comunitaria, Badajoz, España. Electronic address: fbuitragor@gmail.com.
Francisco
F
Buitrago
D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications*; D000069604:Dabigatran / Q000009:adverse effects / Q000627:therapeutic use; D004363:Drug Utilization / Q000706:statistics & numerical data; D065427:Factor Xa Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use; D011728:Pyridones / Q000009:adverse effects / Q000627:therapeutic use; D000069552:Rivaroxaban / Q000009:adverse effects / Q000627:therapeutic use; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D019851:Thrombophilia / Q000188:drug therapy* / Q000209:etiology; D019037:Urban Health Services / Q000706:statistics & numerical data
D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran